Browsing by Subject "Benznidazole"

Adverse Drug Reactions after the use of Benznidazole in Bolivian Patients with Chagas Disease

Silva, Gilberto Marcelo Sperandio da et al. | Date Issued: 2015

Anxiety, depression, and memory loss in Chagas disease: a puzzle far beyond neuroinflammation to be unpicked and solved

Lannes-Vieira, Joseli et al. | Date Issued: 2023

Avaliação da associação do quimioterápico benzonidazol a outros fármacos com ação anti-t cruzi no tratamento da doença de chagas experimental

Almeida, Marcio Cerqueira de | Date Issued: 2013

A doença de Chagas (DC) é causada pelo protozoário hemoflagelado Trypanosoma cruzi. Estima-se que ainda existam 10 milhões de pessoas infectadas na América Latina. Para a quimioterapia específica da DC o benzonidazol (BZ) ...

Benznidazole and amiodarone combined treatment attenuates cytoskeletal damage in Trypanosoma cruzi-infected cardiac cells

Barbosa, Juliana Magalhães Chaves et al. | Date Issued: 2022

Benznidazole decreases the risk of chronic Chagas disease progression and cardiovascular events: A long-term follow up study

Hasslocher-Moreno, Alejandro Marcel et al. | Date Issued: 2021

Benznidazole modulates release of inflammatory mediators by cardiac spheroids infected with Trypanosoma cruzi

Fiuza, Ludmila Ferreira de Almeida et al. | Date Issued: 2021

Benznidazole treatment safety: the Médecins Sans Frontières experience in a large cohort of Bolivian patients with Chagas’ disease

Silva, Gilberto Marcelo Sperandio da et al. | Date Issued: 2017

Benznidazole treatment safety: the Médecins Sans Frontières experience in a large cohort of Bolivian patients with Chagas’ disease - authors’ response

Silva, Gilberto Marcelo Sperandio da et al. | Date Issued: 2018

Benznidazole-resistance in Trypanosoma cruzi: Evidence that distinct mechanisms can act in concert

Campos, Mônica C. O. et al. | Date Issued: 2014

Benznidazole: Hero or villain of cellular immune response in chronic Chagas disease patients?

Soares AKA et al. | Date Issued: 2021

Benznidazole: Hero or villain of cellular immune response in chronic Chagas disease patients?

Soares, Ana K.A. et al. | Date Issued: 2020-01

Benzonidazole adverse events in patients with Chronic Chagas Disease treated at the Instituto de Pesquisa Clínica Evandro Chagas (IPEC) – Fiocruz: preliminary analysis

Silveira, Erica Carvalho da Silva Alves et al. | Date Issued: 2009

Blood leukocytes from benznidazole-treated indeterminate chagas disease patients display an overall type-1-modulated cytokine profile upon short-term in vitro stimulation with Trypanosoma cruzi antigens

Avelar, Renato Sathler et al. | Date Issued: 2012

Characterization of a gene encoding alcohol dehydrogenase in benznidazole-susceptible and -resistant populations of Trypanosoma cruzi

Campos, Fernanda Fraga et al. | Date Issued: 2009

A clinical adverse drug reaction prediction model for patients with Chagas disease treated with benznidazole

Silva, Gilberto Marcelo Sperandio da et al. | Date Issued: 2014

Clinical and laboratory status of patients with chronic Chagas disease living in a vector-controlled area in Minas Gerais, Brazil, before and nine years after aetiological treatment

Lana, Marta de et al. | Date Issued: 2009

Combination Chemotherapy with Suboptimal Doses of Benznidazole and Pentoxifylline Sustains Partial Reversion of Experimental Chagas' Heart Disease

Pereira, Glaucia Vilar et al. | Date Issued: 2016

Combined treatment of heterocyclic analogues and benznidazole upon Trypanosoma cruzi in vivo

Batista, Denise da Gama Jaén et al. | Date Issued: 2011

A comparative study of posaconazole and benznidazole in the prevention of heart damage and promotion of trypanocidal immune response in a murine model of Chagas disease

Olivieri, Bianca P. et al. | Date Issued: 2010

Correction to: in vivo and in vitro taste assessment of artesunate-mefloquine, praziquantel, and benznidazole drugs for neglected tropical diseases and pediatric patients

Boniatti, Janine et al. | Date Issued: 2022